Research Frontiers

Advancing the clinical understanding of neuromodulation and mental health.

Research Update
October 12, 2025
Exploring Deep Brain Stimulation: A new frontier for treatment-resistant depression
Clinical Trial
January 14, 2026
Broaden Study announces new awareness initiative for upcoming neuromodulation trials
Industry Insight
March 05, 2026
Understanding the "Brain Pacemaker": How implantable tech regulates mood
Clinical Intervention
March 4, 2026
The first multicenter pivotal trial for DBS in depression.
Neuroimaging
December 30, 2025
Identifying the Medial Forebrain Bundle as a primary target for mood regulation.
Future Tech
February 05, 2026
Devices that respond to real-time neural biomarkers.
Email
support@broadenstudy.com
Phone
(888) 574-9174
Pages
HomeAboutEligibility ScreenerResearch ProcessParticipant PathwaysResearchNeural Circuit Explorer
Company
Terms of ServicePrivacy PolicyContact Us
© Broaden Study All Rights Reserved
Broaden Study is a clinical research and mental health innovation platform. The information provided on this website is for educational and research awareness purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Deep brain stimulation (DBS) is an investigational or specialized therapy that carries specific risks and safety considerations which should be discussed thoroughly with a clinical professional.